Table 4 Putative Role of the associated variants with NSCLC in JandK Population—North India using the information from the different online databases including GTEX, UCSC genome browser and HSF.

From: Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians

Variant

Allele Ref/Alt

eQTL gene

eQTL Tissue

eQTL sample size

eQTL NES

eQTL p value

eQTL m-value

Putative role (cis-eQTL) of variant

Regulatory role of variant (ENCODE and Haploreg data)

Splicing effect

rs12190287

C/G

TCF21

Lung

515

0.29

1.9E − 17

1

Significant and Up regulation

3_TxFlnk/3_PromD1/H3K4me1_Enh/H3K4me3_Pro/H3K27ac_Enh/H3K9ac_Pro/23_PromBiv

Creation of new site/ broken site for 9G8

rs751402

A/G

ERCC5

Lung

515

0.14

6.2E − 4

1

Significant and Up regulation

1_TssA/H3K4me3_Pro/H3K27ac_Enh/H3K9ac_Pro/H3K4me1_Enh/DNase

Creation of new site for Tra2-β/ broken site for SRp40

rs4986764

A/G

BRIP1

Lung

515

 − 0.09

3.8E − 3

0.985

Significant and Down regulation

NA

Site broken for SRp40

rs2298881

A/C

ERCC1

Lung

515

 − 0.36

2.4E − 15

1

Significant and Down regulation

1_TssA/3_PromD1/H3K4me1_Enh/H3K4me3_Pro/H3K27ac_Enh/H3K9ac_Pro DNase hypersensitive

Site broken for SRp40

rs4757151

A/G

ARNTL/BTBD10

Lung

515

0.002

0.9

0.04

Not Significant

H3K4me1_Enh

Creation of new site/broken site for SC35

rs11615

G/A

ERCC1

Lung

515

 − 0.05

0.1

0.6

Not Significant

11_TxEnh3/H3K4me1_Enh/H3K27ac_Enh/6_EnhG

Creation of new site/ broken site for SF2/ASF (IgM/BRCA1), SF2/ASF and G98

CD3EAP

 − 0.14

4.8E − 7

1

Significant and down regulation

  1. *Represents risk allele in this study; NES—Normalized Effect Size in eQTL; m-value—posterior probability that effect exists in each tissue, ranges between 0 and 1; H3K27Ac_Enh—chemical modification (acetylation) of the histone proteins (H3) at lysine 27 and associated with transcriptional initiation and open chromatin structure (active enhancer); H3K4me3–chemical modification (methylation) of the histone proteins (H3) at lysine 4, marks promoters that are active or poised to be activated; H3K4me1—chemical modification (methylation) of the histone proteins (H3) at lysine 4 and is associated with enhancers, and downstream of transcription starts.; H3K9ac—chemical modification (acetylation) of the histone proteins (H3) at lysine 9 and is associated with transcriptional initiation and open chromatin structure; Enh—Enhancers; Pro—Promoters; TSSA—active transcription start site; TxReg—transcription regulatory; PromD1—promoter downstream TSS; TSSAFlk—Flanking TSS; 22PromP—poised promoter; EnhW1—weak enhancer; EnhA2—active enhancer 2; the H3K4me1/2/3 and H3K36me2/3 are linked with genomic region which actively transcribing and H3K9me3, H3K27me3 and H4K20me3 with non-transcribing region; ESE—Exonic Splicing Enhancers; SR—Serine-Arginine rich proteins; 9G8, SC35—SR splicing factor; SF2/ASF (IgM-BRCA1)—Serine-Arginine rich proteins.